A2AR and VISTA have emerged as critical immune checkpoints that play a significant role in immune escape within breast cancer, with their upregulation impairing immune surveillance and fostering a microenvironment that supports tumor progression (45, 46). This evidence concerns the gene ADORA2A and breast cancer.